PRDX1
Peroxiredoxin-1
Also known as: NKEFA, PAGA, PRDX1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q06830
- Gene
- PRDX1
- Ensembl
- ENSG00000117450
- Chromosome
- 1
- Canonical length
- 199 aa
- Protein class
- Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Mitochondria
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the peroxiredoxin family of antioxidant enzymes, which reduce hydrogen peroxide and alkyl hydroperoxides. The encoded protein may play an antioxidant protective role in cells, and may contribute to the antiviral activity of CD8(+) T-cells. This protein may have a proliferative effect and play a role in cancer development or progression. Four transcript variants encoding the same protein have been identified for this gene. [provided by RefSeq, Jan 2011]
Canonical amino-acid sequenceUniProt
199 residues, UniProt reviewed canonical sequence.
>Q06830|PRDX1
1 MSSGNAKIGH PAPNFKATAV MPDGQFKDIS LSDYKGKYVV FFFYPLDFTF VCPTEIIAFS
61 DRAEEFKKLN CQVIGASVDS HFCHLAWVNT PKKQGGLGPM NIPLVSDPKR TIAQDYGVLK
121 ADEGISFRGL FIIDDKGILR QITVNDLPVG RSVDETLRLV QAFQFTDKHG EVCPAGWKPG
181 SDTIKPDVQK SKEYFSKQKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PRDX1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 987 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 987 nTPM
- liver: 786 nTPM
- thyroid gland: 752 nTPM
- midbrain: 735 nTPM
- kidney: 732 nTPM
- spinal cord: 729 nTPM
Single-cell type
- esophageal suprabasal cells: 3,653 nCPM
- esophageal apical cells: 3,623 nCPM
- esophageal basal cells: 2,324 nCPM
- extravillous trophoblasts: 2,279 nCPM
- hofbauer cells: 1,659 nCPM
- conjunctival goblet cells: 1,637 nCPM
Immune cell
- basophil: 471 nTPM
- T-reg: 439 nTPM
- total PBMC: 416 nTPM
- non-classical monocyte: 409 nTPM
- intermediate monocyte: 368 nTPM
- classical monocyte: 326 nTPM
Brain region
- white matter: 567 nTPM
- medulla oblongata: 463 nTPM
- spinal cord: 454 nTPM
- midbrain: 449 nTPM
- hypothalamus: 435 nTPM
- cerebellum: 427 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.91
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.2
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- canonical NF-kappaB signal transduction
- cell population proliferation
- cell redox homeostasis
- erythrocyte homeostasis
- fibroblast proliferation
- hydrogen peroxide catabolic process
- leukocyte activation
- natural killer cell activation
- natural killer cell mediated cytotoxicity
- regulation of non-canonical NF-kappaB signal transduction
- regulation of stress-activated MAPK cascade
- removal of superoxide radicals
- response to oxidative stress
- skeletal system development
Molecular functions
- cadherin binding
- identical protein binding
- peroxidase activity
- RNA binding
- thioredoxin peroxidase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PRDX1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PRDX1 as an antibody target. Whether an autoantibody or antibody against PRDX1 could matter depends on whether native PRDX1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PRDX1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PRDX1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...